CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations

Residual androgen receptor (AR)-signaling and presence of cancer stem-like cells (SCs) are the two emerging paradigms for clinically challenging castration-resistant prostate cancer (CRPC). Therefore, identification of AR-target proteins that are also overexpressed in the cancer SC population would...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Khanna, Anchit, Rane, Jayant K., Kivinummi, Kati K., Urbanucci, Alfonso, Helenius, Merja A., Tolonen, Teemu T., Saramäki, Outi R., Latonen, Leena, Manni, Visa, Pimanda, John E., Maitland, Norman J., Westermarck, Jukka, Visakorpi, Tapio
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2015
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4637312/
https://ncbi.nlm.nih.gov/pubmed/25965834
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items